Seyffert, J., & Steffes, W. (2019). Vitiligo following alemtuzumab therapy in multiple sclerosis: a demonstration of secondary autoimmunity. International Journal of Research in Dermatology, 5(4), 882–884. https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20194687